BIO-key International (NASDAQ:BKYI) Releases Q4 2023 Earnings Guidance

BIO-key International (NASDAQ:BKYI) updated its fourth quarter 2023 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of -5.540–5.540 for the period. The company issued revenue guidance of -. BIO-key International also updated its FY 2023 guidance to -11.450–11.450 EPS.

BIO-key International Stock Up 2.9 %

NASDAQ:BKYI traded up $0.06 on Monday, hitting $2.16. 45,206 shares of the company’s stock were exchanged, compared to its average volume of 157,179. The company has a market cap of $1.64 million, a P/E ratio of -0.13 and a beta of 0.41. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.30 and a quick ratio of 0.59. BIO-key International has a 52 week low of $1.74 and a 52 week high of $15.30. The firm has a 50-day moving average price of $1.97 and a 200-day moving average price of $3.73.

About BIO-key International

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.